Research Institute Advisory Council members utilize their diverse experiences to define a successful strategy for the Massachusetts General Hospital Research Institute.

Research Institute Advisory Council Members

The Massachusetts General Hospital Research Institute Advisory Council (RIAC) helps to define a successful strategy to keep Mass General research positioned at the forefront of the scientific discovery, and responsive to the emerging opportunities and extraordinary challenges that impact the future of medicine. For more information, contact Kate Gutierrez, Director of Development for Research.


David Altshuler, MD, PhD
Chair, Research Institute Advisory Council
Executive Vice President, Global Research and Chief Scientific Officer, Vertex Pharmaceuticals

Robert Kingston, PhD

Vice Chairman, Research Institute Advisory Council
Chief, Department of Molecular Biology, Massachusetts General Hospital

Dennis A. Ausiello, MD
 
Director, Center for Assessment Technology and Continuous Health (CATCH), Massachusetts General Hospital

James I. Cash, Jr., PhD
Professor and Senior Associate Dean (Emeritus), Harvard Business School

Brit J. d'Arbeloff

Scott Eston

David Fisher, MD, PhD
Vice Chair, Executive Committee on Research
Chief, Department of Dermatology, Massachusetts General Hospital
Ex-officio

Jean-Francois Formela, MD
Partner, Atlas Ventures

James C. Foster
Chairman, President & Chief Executive Officer, Charles River Laboratories

Ansbert Gadicke, MD
Managing Director, MPM Capital

Steve Gorlin
Principal and Founder, Gorlin Companies

Jean de Gunzburg, PhD
Chief Scientific Officer, Da Volterra

Robert F. Higgins
Founding Partner, Highland Capital Partners

Rajiv Kaul
Portfolio Manager, Fidelity Investments

David Louis, MD
Past Chair, Executive Committee on Research 
Chief, Department of Pathology, Massachusetts General Hospital
Ex-officio

Harry Orf, PhD
Senior Vice President for Research, Massachusetts General Hospital
Ex-officio

James F. Orr, III
Former Chairman, The Rockefeller Foundation

John T. Potts, Jr., MD
Director of Research, Emeritus, Physician-in-Chief, Emeritus, Massachusetts General Hospital

Phyllis E. Rappaport
Co-Founder, Cure Alzheimer's Fund

Elizabeth G. Riley, MBA

Michael Rosenblatt, MD

Chief Medical Officer, Flagship Pioneering

Susan A. Slaugenhaupt, PhD
Scientific Director, Massachusetts General Hospital Research Institute
Ex-officio

Peter Slavin, MD
President, Massachusetts General Hospital
Ex-officio

Jack Szostak, PhD
Ex-officio

Mason Tenaglia
Independent Consultant

Robert I. Tepper, MD
Partner, Third Rock Ventures